Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.

Chen Z, Cox KS, Tang A, Roman J, Fink M, Kaufhold RM, Guan L, Xie A, Boddicker MA, Mcguinness D, Xiao X, Li H, Skinner JM, Verch T, Retzlaff M, Vora KA.

BMC Infect Dis. 2018 Dec 4;18(1):613. doi: 10.1186/s12879-018-3517-7.

2.

Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.

Caro-Aguilar I, Indrawati L, Kaufhold RM, Gaunt C, Zhang Y, Nawrocki DK, Giovarelli C, Winters MA, Smith WJ, Heinrichs J, Skinner JM.

Vaccine. 2017 Feb 7;35(6):865-872. doi: 10.1016/j.vaccine.2016.12.055. Epub 2017 Jan 10. Review.

PMID:
28087148
3.

Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.

Wen Z, Boddicker MA, Kaufhold RM, Khandelwal P, Durr E, Qiu P, Lucas BJ, Nahas DD, Cook JC, Touch S, Skinner JM, Espeseth AS, Przysiecki CT, Zhang L.

BMC Microbiol. 2016 Jul 27;16(1):165. doi: 10.1186/s12866-016-0787-3.

4.

Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leads.

Caulfield MJ, Dudkin VY, Ottinger EA, Getty KL, Zuck PD, Kaufhold RM, Hepler RW, McGaughey GB, Citron M, Hrin RC, Wang YJ, Miller MD, Joyce JG.

J Biol Chem. 2010 Dec 24;285(52):40604-11. doi: 10.1074/jbc.M110.172197. Epub 2010 Oct 13.

5.

A real-time quantitative polymerase chain reaction assay for the detection of Chlamydia in the mouse genital tract model.

Wooters MA, Kaufhold RM, Field JA, Indrawati L, Heinrichs JH, Smith JG.

Diagn Microbiol Infect Dis. 2009 Feb;63(2):140-7. doi: 10.1016/j.diagmicrobio.2008.10.007. Epub 2008 Nov 21.

PMID:
19026505
6.

Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions.

Smith JG, Joseph HR, Green T, Field JA, Wooters M, Kaufhold RM, Antonello J, Caulfield MJ.

Clin Vaccine Immunol. 2007 May;14(5):527-37. Epub 2007 Mar 21.

7.

Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.

Kaufhold RM, Field JA, Caulfield MJ, Wang S, Joseph H, Wooters MA, Green T, Clark HF, Krah D, Smith JG.

J Virol. 2005 May;79(9):5684-94.

8.

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.

J Infect Dis. 2003 Nov 1;188(9):1336-44. Epub 2003 Oct 17.

PMID:
14593591
9.

Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.

Smith JG, Levin M, Vessey R, Chan IS, Hayward AR, Liu X, Kaufhold RM, Clair J, Chalikonda I, Chan C, Bernard M, Wang WW, Keller P, Caulfield MJ.

J Med Virol. 2003;70 Suppl 1:S38-41.

PMID:
12627485
10.

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ.

Clin Diagn Lab Immunol. 2001 Sep;8(5):871-9.

Supplemental Content

Loading ...
Support Center